No abstract available
MeSH terms
-
Administration, Oral
-
Antineoplastic Agents / therapeutic use*
-
Disease-Free Survival
-
Humans
-
Immunoglobulin Heavy Chains / genetics
-
Immunoglobulin Variable Region / genetics
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Leukemia, Lymphocytic, Chronic, B-Cell / genetics
-
Leukemia, Lymphocytic, Chronic, B-Cell / mortality
-
Mutation
-
Vidarabine / analogs & derivatives*
-
Vidarabine / therapeutic use
-
ZAP-70 Protein-Tyrosine Kinase / genetics
Substances
-
Antineoplastic Agents
-
Immunoglobulin Heavy Chains
-
Immunoglobulin Variable Region
-
ZAP-70 Protein-Tyrosine Kinase
-
ZAP70 protein, human
-
Vidarabine
-
fludarabine